Опыт применения ритуксимаба у больного системным вариантом ювенильного ревматоидного артрита

К Б Исаева, Ekaterina I. Alexeeva, Rina V. Denisova et al. · CyberLeninK (CyberLeninka) · 2009

The article gives a case report on patient with severe systemic type of juvenile arthritis, refractory to treatment with classical immuno suppressants and blocker of tumor necrotizing factor Successive application of biological agent — rituximab was described. In 9 weeks, extra articular symptoms of disease and acute inflammatory lesions in joints were stopped, and functional activity of child increased. Presented case report demonstrates high effectiveness of rituximab: patient with severe systemic type of juvenile arthritis has clinical and laboratory remission of disease during 12 months. Key words: children, juvenile rheumatoid arthritis, rituximab. ( Voprosy sovremennoi pediatrii —  Current Pediatrics. 2009;8(3): 132-138 )

Cited by 0 works.

Authors